The relationship between A1C and average blood sugar follows a predictable pattern
Plaintiffs in these actions allege that manufacturers, primarily Novo Nordisk and Eli Lilly, failed to adequately warn prescribers and consumers about the risk of NAION and sudden vision loss associated with GLP1 drugs
Dr South said the risk appears to be greatest when people first start taking the medication, or when increasing their dosage, but that a significant delay in gastric emptying is not there a year down the track
As always, financing is available, and we can provide details on payment options at your consultation
Avoid drawing the needle through the rubber stopper (cap)
Compared with long-acting insulin, GLP-1RA therapy reduces the risk of composite liver disease (cirrhosis or hepatocellular carcinoma) in patients with type 2 diabetes by 44%, with a 41% reduction in cirrhosis risk and a 53% reduction in hepatocellular carcinoma risk